Vinorelbine (Navelbine): Supply issue resolved
The registered brand, Navelbine, is now back in stock.
Update: 3 February 2022
The approved Navelbine brand of vinorelbine is back in stock.
Alternative product was sourced
We listed the Sagent brand of vinorelbine from 1 September 2021 to ensure continuity of supply. Sagent brand vinorelbine is not Medsafe-approved. It had to be prescribed and supplied in line with section 29 of the Medicines Act.
We worked with the Cancer Treatments Subcommittee, medical oncologists, the Cancer Control Agency, and District Health Board (DHB) hospitals to minimise any impact to patients.
This was a global issue
The supplier advised Pharmac that there was a global supply issue with vinorelbine solution for injection.